Similarities and differences between axial spondyloarthritis and axial psoriatic arthritis

Article Rheumatology

Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis

Iain B. McInnes et al.

Summary: In patients with active psoriatic arthritis, guselkumab provided durable improvements in multiple disease domains over a 2-year period with no unexpected safety findings.

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Laura C. Coates et al.

Summary: This article presents evidence-based treatment recommendations for Psoriatic Arthritis (PsA) medication selection, covering various clinical domains, related conditions and comorbidities. It provides important guidance and support for clinicians and individuals with PsA.

NATURE REVIEWS RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status?

Laura C. Coates et al.

Summary: Patients with axial spondyloarthritis (SpA) who are positive for HLA-B27 exhibit more severe radiographic damage, more marginal syndesmophytes, and more frequent syndesmophyte symmetry compared to HLA-B27 negative patients.

ARTHRITIS CARE & RESEARCH (2021)

Add to Collection

Meeting Abstract Rheumatology